BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8585081)

  • 1. [Treatment of severe neutropenias in dogs and cats with filgrastim].
    Kraft W; Kuffer M
    Tierarztl Prax; 1995 Dec; 23(6):609-13. PubMed ID: 8585081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [G-CSF (Neupogen Roche) in the treatment of patients with chronic aplastic anemia with severe neutropenia].
    Novotný J; Zvarová M; Prazáková L; Jandlová M; Konvicková L
    Vnitr Lek; 1995 Oct; 41(10):692-5. PubMed ID: 8578701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis.
    Mischke R; Barth T; Wohlsein P; Rohn K; Nolte I
    Res Vet Sci; 2001 Jun; 70(3):221-5. PubMed ID: 11676617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection.
    Rewerts JM; McCaw DL; Cohn LA; Wagner-Mann C; Harrington D
    J Am Vet Med Assoc; 1998 Oct; 213(7):991-2. PubMed ID: 9776994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
    Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
    Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
    Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
    An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
    [No Abstract]   [Full Text] [Related]  

  • 8. Granulocytic growth factors and cancer-related neutropenia: limited effects.
    Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a point-of-care hematology analyzer for use in dogs and cats receiving chemotherapeutic treatment.
    Lara-Garcia A; Hosoya K; Iazbik C; Westendorf N; Gallant S; Couto G
    J Am Vet Med Assoc; 2008 May; 232(10):1488-95. PubMed ID: 18479238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
    Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
    Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics].
    Ersbøll J
    Ugeskr Laeger; 1991 Sep; 153(38):2647-50. PubMed ID: 1719682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Filgrastim in the treatment of severe neutropenia in a patient with bilobar pneumonia].
    Marcos Sánchez F; Juárez Ucelay F; Plaza Díaz R; Durán Pérez-Navarro A
    An Med Interna; 1995 Feb; 12(2):100-1. PubMed ID: 7538330
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
    Peddi VR; Hariharan S; Schroeder TJ; First MR
    Clin Transplant; 1996 Feb; 10(1 Pt 1):20-3. PubMed ID: 8652892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adult dog with cyclic neutropenia treated by lentivirus- mediated delivery of granulocyte colony-stimulating factor.
    Yanay O; Brzezinski M; Christensen J; Liggitt D; Dale DC; Osborne WR
    Hum Gene Ther; 2006 Apr; 17(4):464-9. PubMed ID: 16610934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using filgrastim efficiently.
    Dranitsaris G
    Pharmacoeconomics; 1996 May; 9(5):466-8. PubMed ID: 10161379
    [No Abstract]   [Full Text] [Related]  

  • 19. [An update on viral diseases of the dog and cat].
    Bodewes R; Egberink HF
    Tijdschr Diergeneeskd; 2009 Apr; 134(8):330-6. PubMed ID: 19462619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filgrastim: new indication. AIDS-associated neutropenia: another soft indication.
    Prescrire Int; 2001 Aug; 10(54):106-7. PubMed ID: 11718177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.